Corporate

Corporate

Breaking Barriers in Science: The Women of DoubleRainbow Biosciences

11 Feb 2023

Corporate

2022: The year of acceleration

By Cavan Farley

30 Dec 2022

Corporate

Landkind Reaches Significant Regulatory Milestone, achieving GRAS Status for LK-01 Pure Salidroside

Press Release

19 Dec 2022

Corporate

Double Rainbow Announces World’s First Commercial-Scale Biosynthetic Gastrodin, a Natural Analgesic with a Range of Therapeutic Applications

Press Release

28 Nov 2022

Corporate

DoubleRainbow Biosciences Announces Strategic AI Collaboration with Galixir

Press Release

7 Nov 2022

Corporate

DoubleRainbow Biosciences and Landkind to Participate in SupplySide West Conference October 31 - November 4

Press Release

25 Oct 2022

Corporate

Double Rainbow Announces Membership with BioMADE

Press Release

20 Oct 2022

Corporate

DoubleRainbow Biosciences and Kelai Pharmaceuticals to collaborate on novel natural compound therapeutics

Press Release

22 Aug 2022

Corporate

Landkind launches LK-01 Pure Salidroside for cognitive and athletic performance

Press Release

6 Jul 2022

Corporate

Double Rainbow launches Landkind to deliver a new class of sustainable wellness products

Press Release

4 Apr 2022

Corporate

2021: A year in Review

By Cavan Farley

23 Dec 2021

Corporate

Double Rainbow announces $10 million investment from Betta Pharmaceuticals

Press Release

10 Aug 2021